Enrolling By InvitationNCT07345858

Salivary Oxytocin as a Biomarker of Psychedelic Treatment

This enrolling by invitation study focuses on depression and currently lists sites or participation links in Switzerland.

DepressionOtherOver 18 Years

In plain English

Key information made simple

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers could change in day-to-day care and decision-making. For people living with Depression, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including Geneva University Hospitals in Geneva. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually having a stable enough treatment background for the study, while common reasons not to take part include safety concerns that need urgent care first and major medical issues that could make participation unsuitable. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT07345858. Your email is the only field you need to provide here.

In practice

For you

Taking part may help improve understanding of your condition.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Switzerland.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com